![Anne Marie de Jonge Schuermans](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Presently, Anne Marie de Jonge Schuermans is Head-Technical Operations at Swedish Orphan Biovitrum AB. She previously held the position of Member-Executive Board at Biogen International GmbH. She received a graduate degree from École Polytechnique Fédérale de Lausanne, a doctorate from Swiss Federal Institute of Technology and a graduate degree from Wageningen University.
Former positions of Anne Marie de Jonge Schuermans
Companies | Position | End |
---|---|---|
SWEDISH ORPHAN BIOVITRUM AB | Chief Tech/Sci/R&D Officer | 2021-12-31 |
Biogen International GmbH
![]() Biogen International GmbH Pharmaceuticals: MajorHealth Technology Biogen International GmbH produces pharmaceuticals. It develops medicines for psoriasis and multiple sclerosis. Its products include FUMADERM and BG-12. The company was founded in 1983 and is headquartered in Lucerne, Switzerland. | Corporate Officer/Principal | 2018-09-30 |
PHARVARIS N.V. | Director/Board Member | - |
Training of Anne Marie de Jonge Schuermans
École Polytechnique Fédérale de Lausanne | Graduate Degree |
Swiss Federal Institute of Technology | Doctorate Degree |
Wageningen University | Graduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
PHARVARIS N.V. | Health Technology |
Private companies | 1 |
---|---|
Biogen International GmbH
![]() Biogen International GmbH Pharmaceuticals: MajorHealth Technology Biogen International GmbH produces pharmaceuticals. It develops medicines for psoriasis and multiple sclerosis. Its products include FUMADERM and BG-12. The company was founded in 1983 and is headquartered in Lucerne, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Anne Marie de Jonge Schuermans